DNA Link Inc Cash Flow Reinvestment Rate

Latest as of December 2023: 1.64x

DNA Link Inc cash flow reinvestment rate. DNA Link Inc (127120) has a Cash Flow Reinvestment Rate of 1.64x as of December 2023, reinvesting ₩2.48 Billion (capex ₩786.91 Million plus investments ₩-1.69 Billion) from operating cash flow of ₩1.51 Billion. See DNA Link Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.64x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.48 Billion
Capex + Investments

Operating Cash Flow

₩1.51 Billion
KRW

Capital Expenditures

₩786.91 Million
KRW

Cash Flow Reinvestment Rate of DNA Link Inc (2020–2022)

Cash flow reinvestment rate of DNA Link Inc from 2020 to 2022. Historical reinvestment intensity for DNA Link Inc across 2 annual periods. Explore DNA Link Inc (127120) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

DNA Link Inc Cash Flow Reinvestment Rate by Year (2020–2022)

DNA Link Inc cash flow reinvestment rate by year from 2020 to 2022. Year-by-year capital reinvestment analysis for DNA Link Inc. For the full cash flow conversion analysis, see cash efficiency ratio of DNA Link Inc.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 8.36x ₩7.61 Billion ₩910.27 Million ₩4.93 Billion ▲ +104.1%
2020 4.09x ₩3.48 Billion ₩849.38 Million ₩1.10 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow